Amiko Digital Health, a company based in London, UK, landed CE Mark approval for its Respiro sensors and accompany platform to be used with Teva’s Spiromax , Chiesi’s Nexthaler and GlaxoSmithKline’s Ellipta inhalers.
The Respiro system records usage of an inhaler every time it’s accessed, passing that information in real-time to a patient (Read more...)